Literature DB >> 12419246

Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling.

Jia Wei Wu1, Ariel R Krawitz, Jijie Chai, Wenyu Li, Fangjiu Zhang, Kunxin Luo, Yigong Shi.   

Abstract

The Ski family of nuclear oncoproteins represses TGF-beta signaling through interactions with the Smad proteins. The crystal structure of the Smad4 binding domain of human c-Ski in complex with the MH2 domain of Smad4 reveals specific recognition of the Smad4 L3 loop region by a highly conserved interaction loop (I loop) from Ski. The Ski binding surface on Smad4 significantly overlaps with that required for binding of the R-Smads. Indeed, Ski disrupts the formation of a functional complex between the Co- and R-Smads, explaining how it could lead to repression of TGF-beta, activin, and BMP responses. Intriguingly, the structure of the Ski fragment, stabilized by a bound zinc atom, resembles the SAND domain, in which the corresponding I loop is responsible for DNA binding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419246     DOI: 10.1016/s0092-8674(02)01006-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  69 in total

1.  Transposon mutagenesis with coat color genotyping identifies an essential role for Skor2 in sonic hedgehog signaling and cerebellum development.

Authors:  Baiping Wang; Wilbur Harrison; Paul A Overbeek; Hui Zheng
Journal:  Development       Date:  2011-10       Impact factor: 6.868

2.  ZAS3 accentuates transforming growth factor β signaling in epithelial cells.

Authors:  Adam J Yakovich; Bo Jiang; Carl E Allen; Jianguo Du; Lai-Chu Wu; John A Barnard
Journal:  Cell Signal       Date:  2010-08-21       Impact factor: 4.315

3.  Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.

Authors:  Ariel R Krakowski; Julien Laboureau; Alain Mauviel; Mina J Bissell; Kunxin Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

Review 4.  The structures that underlie normal reproductive function.

Authors:  Thomas F Lerch; Min Xu; Theodore S Jardetzky; Kelly E Mayo; Ishwar Radhakrishnan; Ralph Kazer; Lonnie D Shea; Teresa K Woodruff
Journal:  Mol Cell Endocrinol       Date:  2006-11-30       Impact factor: 4.102

5.  A reinforced merging methodology for mapping unique peptide motifs in members of protein families.

Authors:  Hao-Teng Chang; Tun-Wen Pai; Tan-chi Fan; Bo-Han Su; Pei-Chih Wu; Chuan-Yi Tang; Chun-Tien Chang; Shi-Hwei Liu; Margaret Dah-Tsyr Chang
Journal:  BMC Bioinformatics       Date:  2006-01-25       Impact factor: 3.169

6.  AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis.

Authors:  Malik Bisserier; Javier Milara; Yassine Abdeldjebbar; Sarah Gubara; Carly Jones; Carlos Bueno-Beti; Elena Chepurko; Erik Kohlbrenner; Michael G Katz; Sima Tarzami; Julio Cortijo; Jane Leopold; Roger J Hajjar; Yassine Sassi; Lahouaria Hadri
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

7.  Deciphering the Pathogenic Nature of Two de novo Sequence Variations in a Patient with Shprintzen-Goldberg Syndrome.

Authors:  Priyanka Srivastava; Shashank Shende; Kausik Mandal
Journal:  Mol Syndromol       Date:  2021-05-06

8.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

9.  Structure of Drosophila Mad MH2 domain.

Authors:  Rui Hao; Lei Chen; Jia-Wei Wu; Zhi-Xin Wang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

10.  Assessing the druggability of protein-protein interactions by a supervised machine-learning method.

Authors:  Nobuyoshi Sugaya; Kazuyoshi Ikeda
Journal:  BMC Bioinformatics       Date:  2009-08-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.